SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-011122
Filing Date
2022-05-05
Accepted
2022-05-05 16:03:03
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20220331_10q.htm   iXBRL 10-Q 750852
2 EXHIBIT 31.1 ex_355181.htm EX-31.1 15819
3 EXHIBIT 31.2 ex_355182.htm EX-31.2 15396
4 EXHIBIT 32.1 ex_355183.htm EX-32.1 8597
  Complete submission text file 0001437749-22-011122.txt   3859375

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20220331.xsd EX-101.SCH 40032
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20220331_cal.xml EX-101.CAL 23646
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20220331_def.xml EX-101.DEF 292017
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20220331_lab.xml EX-101.LAB 244592
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20220331_pre.xml EX-101.PRE 303032
45 EXTRACTED XBRL INSTANCE DOCUMENT wint20220331_10q_htm.xml XML 479615
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 22896076
SIC: 2836 Biological Products, (No Diagnostic Substances)